ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
34 hedge funds and large institutions have $5.57M invested in Argos Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Holders
34
Holding in Top 10
1
Calls
$1.95M
Puts
$25K
Top Buyers
| 1 | +$70K | |
| 2 | +$40K | |
| 3 | +$30K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$17K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$16.5K |
Top Sellers
| 1 | -$252K | |
| 2 | -$99K | |
| 3 | -$85K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$57.9K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$57K |